SupplementaryFigure.docx (14.77 kB)

Supplementary Figure 1 - Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: a systematic literature review

figure

posted on 24.02.2022, 09:33 by T. Alexander Russell-Smith, Laura Gurskyte, Bogdan Muresan, Carla M. Mamolo, Ana Gezin, Joseph C. Cappelleri, Bart Heeg

Supplementary Figure 1. Quality assessment of the included studies

Treatment patterns and economic burden among newly diagnosed cervical and endometrial cancer patients

Funding

Pfizer

History

Usage metrics

Read the peer-reviewed publication

Resource title* Efficacy of non-intensive therapies approved for relapsed/refractory acute myeloid leukemia: A systematic literature review

Future Oncology

Keywords

AML leukemia relapsed not eligible unfit review Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0